[Anticardiolipin antibodies in elderly patients with venous thromboembolic diseases in an area of the south of Extremadura (Spain)].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J M Calvo Romero.
Explore the source record for details and available documents.
In this article we briefly review the evidence on the effect of different "natural" products on cholesterolemia. Plant stanols and sterols reduce cholesterol intestinal absorption and decrease total and LDL cholesterol by approximately 10%. Polycosanol is a mixture of saturated alcohols that seem to inhibit cholesterol hepatic synthesis and decrease total and LDL cholesterol by up to 25%. The effects on the cholestorolemia of soy and soluble fiber are modest.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
OBJECTIVE: To know in our area the security of no long-term anticoagulation in patients with suspected pulmonary thromboembolism (PTE) and a low probability ventilation/perfusion (V/Q) lung scan. MATERIAL AND METHODS: Retrospective review of a series of consecutive outpatients with suspected PTE and a low probability V/Q lung scan, according to the modified PIOPED criteria, who receive no long-term anticoagulation. RESULTS: Among 38 patients with a low probability V/Q lung scan, 31 (81.6%) did not receive long-term anticoagulation. The median age was 69.1 years (range 26-88 years), and 19 (61.3%) were female. The clinical probability of PTE was moderate in 27 patients (87.1%). Twenty-two patients (71%) had a venous lower extremities echography-doppler negative for deep vein thrombosis (DVT). The median follow-up was 6.3 months (range 3-12 months). There was one case (3.2%; 95% confidence interval, 0.1-16.7%) with demonstrated PTE and DVT, and there was no death. CONCLUSION: No long-term anticoagulation in outpatients with a moderate clinical probability of PTE, a low probability V/Q lung scan and a venous lower extremities echography-doppler negative for DVT may be secure in our area.
OBJECTIVE: To study the characteristics of the venous thromboembolic disease (VTD) in a rural area of Southern Extremadura (Spain). MATERIAL AND METHODS: Prospective observational study of all patients diagnosed by objective methods of VTD in the only hospital in our area from November 2002 to November 2004. RESULTS: Seventy-six patients were diagnosed of VTD: 35 (46.1%) with pulmonary thromboembolism and 41 (53.9%) with isolated deep vein thrombosis (DVT). The median age was 72.4 years (range 35-94 years), 51 (67.1%) were older than 70 years, and 43 (56.6%) were women. The annual incidence of VTD was 0.63 per 1,000 persons (0.74 per 1,000 persons in women and 0.54 per 1,000 persons in men). Thirty-seven patients (48.7%) had "idiopathic" VTD. After a median follow-up of 5.5 months with anticoagulant therapy, 13 patients (17.1%) had dead. Comorbidity and non "idiopathic" VTD were significantly more frequent in the dead patients. Three patients (3.9%) presented probable recurrence, and all of them died. There were 4 cases (5.3%) of non-fatal severe hemorrhage. Nine patients with isolated DVT did not require hospitalization, and there was no event in the follow-up. CONCLUSIONS: The incidence of VTD may be lower in our area than in other geographical areas. VTD affects more frequently to elderly and women, and almost half of cases are "idiopathic". The mortality is high, and it is related to the existence of comorbidity and non "idiopathic" VTD. The recurrences and the severe hemorrhages are not exceptional during the anticoagulant therapy. The ambulatory treatment of isolated DVT may be an option in selected patients.
OBJECTIVE: To study the frequency in patients with pulmonary thromboembolism (PTE) of an elevated troponin I and the associated characteristics. MATERIAL AND METHODS: Prospective study of 29 consecutive patients with PTE. RESULTS: Troponin I was determined in 22 patients. The median age was 78.1 years. Ten (45.5%) had an elevated troponin I, with a median level of 1 ng/ml (range 0.7-3.1 ng/ml). The diagnostic delay was lower in patients with an elevated troponin I (2 +/- 1.7 vs. 5.9 +/- 5.6 days, p = 0.04). Three (30%) of 10 patients with an elevated troponin I had midthoracic pain. Patients with an elevated troponin I had a higher frequency of arterial hypotension (40 vs. 16.7%), respiratory failure (70 vs. 58.3%) and electrocardiographic overload right heart data (50% vs. 33.3%), although without reaching statistical significance. CONCLUSIONS: A slightly elevated troponin I is frequent in patients with PTE. The early diagnosis may increase the frequency of an elevated troponin I. The coexistence of an elevated troponin I and midthoracic pain may simulate an acute coronary syndrome. In patients with PTE, an elevated troponin I may associate to some severity criteria such as arterial hypotension, respiratory failure and electrocardiographic overload right heart data.
Explore the source record for details and available documents.
BACKGROUND: The diagnosis of pulmonary thromboembolism (PTE) may be a challenge in many cases, particularly among the elderly patients. OBJECTIVE: To establish the diagnostic utility of D-dimer measurement by a rapid semi-quantitative immunoassay (NycoCard, D-Dimer, normal value < or =0.3 mg/l) in a series of patients with suspected PTE admitted to an Internal Medicine Department. METHODS: Retrospective review of 48 patients admitted to our Department with the clinical suspect of PTE and D-dimer assay, in whom a lung ventilation/perfusion scan was conclusive (high or normal/very low/low probability of PTE). RESULTS: The median age of patients was 67.4 years and 79.2% were older than 60 years. For the diagnosis of PTE, the values of sensitivity, specificity, positive predictive value, and negative predictive value were 95.2%, 55.5%, 62.5% and 93.7%, respectively. When patients with potential confounding factors in the measurement of D-dimer (surgery and/or trauma in the 2 previous weeks, or neoplasm) were excluded, similar results were obtained. CONCLUSIONS: When a normal D-dimer (< or =0.3 mg/l) measurement by a rapid semi-quantitative immunoassay (NycoCard) is obtained, the presence of PTE is very unlikely. An increased D-dimer should lead to additional complementary tests to confirm or rule out PTE. These results apply for patients aged over 60 years and are not influenced by potential confounding factors.
OBJECTIVE: To describe the characteristics of pulmonary thromboembolism (PTE) in the elderly and to identify potential differences between elderly and non-elderly patients. PATIENTS AND METHODS: Retrospective review of 154 consecutive patients diagnosed of PTE in an Internal Medicine service between January 1993 and December 2001. RESULTS: Ninety patients (58.4%) were older than 70 years. Prior cardiopulmonary disease was significantly more frequent in patients older than 70 years (41.1% vs 23.4%, p = 0.03). Deep venous thrombosis (DVT) clinic was significantly less frequent in older than 70 years (36.7% vs 53.1%, p = 0.04). The rest of studied characteristics was similar in both groups. Four patients older than 70 years (4.4%) did not have "classical" symptoms of PTE (dyspnea, centrothoracic pain, pleuritic pain and/or hemoptysis). Three patients older than 70 years (3.3%) did not have "classical" signs of PTE (tachypnea, tachycardia and/or crackles) nor DVT clinic. Three patients older than 70 years (3.3%) had a normal alveolar-arterial oxygen gradient. Hospital death was more frequent in older than 70 years, but without reaching statistical significance (8.9% vs 3.1%, p > 0.05). CONCLUSIONS: PTE characteristics are similar in elderly and in non-elderly patients, although DVT clinic is less frequent in elderly. The absence of "classical" symptoms of PTE, the absence of "classical" signs of PTE and DVT clinic, and a normal alveolar-arterial oxygen gradient are very infrequent in elderly with PTE. Hospital mortality in PTE may be higher in patients older than 70 years.
Explore the source record for details and available documents.
BACKGROUND. Mortality in pulmonary thromboembolism (PTE) decreases considerable when it is diagnosed early. The suspicion based on clinical and complementary data is essential for an early diagnosis. METHODS. Retrospective review of the clinical features in patients diagnosed of PTE in an Internal Medicine department from January 1993 to December 1999. RESULTS. A total of 117 patients with PTE were identified. The median age was 68.8 years. Sixty-six patients (56.4%) had one or more risk factors for PTE. The most common risk factor was immobilization (37.6%). Dyspnea was the most common symptom (74.4%) and tachypnea the most common sign (66.7%). Fever/low grade fever and leukocytosis were present in 16.2% and 31.6% of patients, respectively. Respiratory failure, alkalosis and hypocapnia were present in 44.4%, 38.5% and 47% of patients, respectively. An alveolar-arterial oxygen gradient > 20 mmHg was demonstrated in 96.6% of patients. Chest radiographs and electrocardiograms were normal in 52.1% and 23.9% of patients, respectively. A vein echo-duplex of the lower limbs demonstrated deep vein thrombosis (DVT) in 52.1% of patients. The hospital mortality rate was 6.8%. CONCLUSIONS. PTE still affects older patients mainly and frequently known risk factors are not detected. The presence of fever/low grade fever and/or leukocytosis does not rule out PTE. Both chest radiographs and electrocardiograms may be normal. Not demonstrating DVT in the lower limbs by the vein echo-duplex does not rule out PTE. The hospital mortality rate has not decreased considerably in the last few years.
OBJECTIVE: Antineutrophil cytoplasmic antibodies (ANCA) have been described in a great variety of diseases in addition to the ANCA-associated systemic vasculitis (Wegener's granulomatosis (WG), microscopic polyangiitis (MPA) and Churg-Strauss syndrome (CSS)) and the pauci-immune rapidly progressive glomerulonephritis (RPGN). The objective of this work is to describe the clinical-pathological diagnosis of a series of patients with ANCA. MATERIAL AND METHODS: Retrospective review of patients with positive ANCA by indirect immunofluorescence in our hospital between January 1997 and December 1998. RESULTS: We identify 82 patients with ANCA. Six cases (7.3%) showed a C-ANCA pattern, 19 (23.2%) a P-ANCA pattern and 57 (69.5%) an atypical pattern. Eight patients (9.7%) had an ANCA-associated systemic vasculitis (5 WG, 2 MPA and 1 SCS). Four patients (4.9%) had a pauci-immune RPGN without systemic vasculitis. One only case (1.2%) in our series presented a C-ANCA pattern without evidence of an ANCA-associated systemic vasculitis or a pauci-immune RPGN. CONCLUSIONS: The atypical pattern is the most frequent in patients with ANCA. A minority of patients with ANCA have an ANCA-associated systemic vasculitis (WG, MPA or SCS) or a pauci-immune RPGN. The occurrence of a C-ANCA pattern is exceptional in patients without an ANCA-associated systemic vasculitis or a pauci-immune RPGN.
Explore the source record for details and available documents.
BACKGROUND: Primary antiphospholipid syndrome (APS) is a thrombophilic disorder which is not associated with connective tissue diseases or with other diseases. METHOD: Retrospective review of patients diagnosed of primary APS in an Internal Medicine service between January 1996 and December 2000. RESULTS: We identified 17 patients with primary APS. The most common presenting manifestations were deep vein thrombosis (7 cases) and ischemic stroke (3 cases). Eleven patients (65%) had vein thrombosis, 4 (24%) arterial thrombosis and no patient had both types of thrombosis. The 15 patients with thrombosis received treatment with indefinite oral anticoagulation (INR between 2.5 and 3.5). There was no recurrence of thrombosis or major hemorrhagic complications after a median follow-up time of 36 months (range 10-52 months). CONCLUSIONS: The most common presenting manifestation of primary APS is deep vein thrombosis. Venous thrombosis is more frequent than arterial thrombosis. The occurrence of both types of thrombosis seems to be exceptional. Long-term oral anticoagulation is an effective and safe treatment to prevent the recurrence of thrombosis in patients with primary APS.
Giant cell arteritis (GCA) or temporal arteritis is the most frequent systemic vasculitis in our area, and its incidence may be on the increase in the last years. GCA involves large and medium-sized vessels, with preference to the extracranial arteries, and it affects persons older than 50 years. The aetiopathogenesis is unknown, although several infectious agents may be implicated. A normal temporal artery biopsy do not exclude a GCA since the lesions may be skip. The most feared complications of GCA are permanent visual loss, ischemic strokes and thoracic and abdominal aortic aneurysms. The treatment consists of high-dose corticoids, and nowadays there is no effective therapeutic alternative without important adverse effects. The mortality of treated patients with GCA does not seem to be increased, probably due to a correct diagnosis and management of this entity.
Explore the source record for details and available documents.
Patients with acute cerebrovascular diseases may present a great variety of electrocardiographic abnormalities. Electrocardiographic pattern consistent with acute myocardial infarction (AMI) without biochemical evidence of myocardial necrosis associated with ischemic stroke is exceptional. It is described a 86-year-old woman with an electrocardiographic pattern consistent with AMI, with normal creatinkinase and troponin I levels, associated with a right hemispheric ischemic stroke.